Replies to post #67108 on Biotech Values

[DewDiligence]

Another IDIX tidbit from today’s JMP presentation: JP Sommadossi said Sebivo is now selling “extremely well” in Asia, especially China. This bodes well for IDIX’s royalty income from NVS in 4Q08. (Royalties are recorded with a one-quarter lag.)